Your browser doesn't support javascript.
loading
Canadian Rheumatology Association/Spondyloarthritis Research Consortium of Canada Living Treatment Recommendations for the Management of Axial Spondyloarthritis.
Rohekar, Sherry; Pardo Pardo, Jordi; Mirza, Reza; Aydin, Sibel Z; Bessette, Louis; Richard, Nicolas; Mosher, Dianne; Boyd, Tristan; Chan, Jon; Eder, Lihi; Passalent, Laura; Karam, Elie; Nair, Bindu; Hazlewood, Glen S; Tse, Shirley; Rumsey, Dax; Zummer, Michel; Haroon, Nigil; Inman, Robert; Gladman, Dafna D.
Affiliation
  • Rohekar S; S. Rohekar, MD, Western University, Department of Medicine, Division of Rheumatology, London, Ontario.
  • Pardo Pardo J; J. Pardo Pardo, LDO, Ottawa Hospital Research Institute, University of Ottawa, and Department of Medicine, Faculty of Medicine, University of Ottawa, Ottawa, Ontario.
  • Mirza R; R. Mirza, MD, MSc, Rheumatologist and Methodologist, McMaster University, Hamilton, Ontario.
  • Aydin SZ; S.Z. Aydin, MD, University of Ottawa, Ottawa Hospital Research Institute, Ottawa, Ontario.
  • Bessette L; L. Bessette, MD, MSc, Laval University, Department of Medicine, Quebec City, Quebec.
  • Richard N; N. Richard, MD, Department of Medicine, Université de Montréal, Montreal, and Division of Rheumatology, Hôpital Maisonneuve-Rosemont, Montreal, Quebec.
  • Mosher D; D. Mosher, MD, Department of Medicine, University of Calgary, Calgary, Alberta.
  • Boyd T; T. Boyd, MD, Department of Medicine, Division of Rheumatology, Western University, Hamilton, Ontario.
  • Chan J; J. Chan, MD, Division of Rheumatology, Department of Medicine, University of British Columbia, and Arthritis Research Canada, Vancouver, British Columbia.
  • Eder L; L. Eder, MD, PhD, Department of Medicine, Women's College Hospital, University of Toronto, Toronto, Ontario.
  • Passalent L; L. Passalent, PT, MHSc, ACPAC, Department of Physical Therapy, Temerty Faculty of Medicine, University of Toronto, and Krembil Research Institute, University Health Network, and Division of Rheumatology, Schroeder Arthritis Institute, University Health Network, Toronto, Ontario.
  • Karam E; E. Karam, MD, Department of Family Medicine, University of Ottawa, Ottawa, and Canadian Spondyloarthritis Association, Toronto, Ontario.
  • Nair B; B. Nair, MD, MSc, Division of Rheumatology, Department of Medicine, University of Saskatchewan, Saskatoon, Saskatchewan.
  • Hazlewood GS; G.S. Hazlewood, MD, PhD, Departments of Medicine and Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, Alberta.
  • Tse S; S. Tse, MD, University of Toronto, and Division of Rheumatology, SickKids, Toronto, Ontario.
  • Rumsey D; D. Rumsey, MD, MSc, University of Alberta, Edmonton, Alberta.
  • Zummer M; M. Zummer, MD, Department of Medicine, Université de Montréal, Montreal, and Division of Rheumatology, Hôpital Maisonneuve-Rosemont, Montreal, Quebec.
  • Haroon N; N. Haroon, MD, PhD, DM, University Health Network, Division of Rheumatology, University of Toronto, Schroeder Arthritis Institute, Toronto, Ontario.
  • Inman R; R. Inman, MD, Schroeder Arthritis Institute, and University Health Network, and Department of Medicine and Immunology, University of Toronto, Toronto, Ontario.
  • Gladman DD; D.D. Gladman, MD, Department of Medicine, University of Toronto, and Schroeder Arthritis Institute, Krembil Research Institute, Toronto Western Hospital, and Psoriatic Disease Program, University Health Network, Toronto, Ontario, Canada.
J Rheumatol ; 2024 Aug 01.
Article in En | MEDLINE | ID: mdl-38950949
ABSTRACT

OBJECTIVE:

To provide a set of living treatment recommendations that will give contemporary guidance on the management of patients with axial spondyloarthritis (axSpA) in Canada.

METHODS:

The Spondyloarthritis Research Consortium of Canada (SPARCC), in conjunction with the Canadian Rheumatology Association, organized a treatment recommendations panel composed of rheumatologists, researchers, allied health professionals, and a patient advocate. A Grading of Recommendations Assessment, Development, and Evaluation (GRADE)-ADOLOPMENT approach was used, in which existing guidelines were adopted or adapted to a Canadian context. Recommendations were also placed in a health equity framework.

RESULTS:

Fifty-six recommendations were made for patients with active axSpA, stable axSpA, active or stable axSpA, for comorbidities, and for assessment, screening, and imaging. Recommendations were also made for principles of management, disease monitoring, and ethical considerations.

CONCLUSION:

These living treatment recommendations will provide up-to-date guidance for the management of axSpA for Canadian practice. As part of the living model, they will be updated regularly as changes occur in the treatment landscape.
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: J Rheumatol Year: 2024 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: J Rheumatol Year: 2024 Document type: Article